Applied Dna Sciences Inc

NASDAQ:APDN   3:59:43 PM EDT
6.77
+0.04 (+0.59%)
Products

Applied DNA Says Veterinary Covid-19 Vaccine Candidate Induces Neutralizing Antibodies In 100% Of Trial Cohort Against Some Variants

Published: 06/07/2021 15:29 GMT
Applied Dna Sciences Inc (APDN) - Applied Dna Reports Veterinary Covid-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.
1.1.
7, P1, and B.
1.526 Variants and Sets August 2021 Mink Challenge Trial Launch.
Applied Dna Sciences Inc - Study Showed Neutralizing Antibody Titers Against B.
1.1.
7 Were Not Significantly Impacted.
Applied Dna Sciences Inc - Neutralizing Antibody Titers Against P1 and B.
1.526 Were Reduced As Expected.
Applied Dna Sciences - Believes Reductions in Viral Neutralization Titers Against P1 and B.
1.526 Unlikely to Lead to Reduction in Effectiveness of Vaccine Candidate.